You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial
|
|---|---|
| Published in |
Clinical Cancer Research, November 2020
|
| DOI | 10.1158/1078-0432.ccr-20-0844 |
| Pubmed ID | |
| Authors |
Eva Ciruelos, Patricia Villagrasa, Tomás Pascual, Mafalda Oliveira, Sonia Pernas, Laia Paré, Santiago Escrivá-de-Romaní, Luis Manso, Barbara Adamo, Eduardo Martínez, Javier Cortés, Silvia Vazquez, Antonia Perelló, Isabel Garau, Mireia Melé, Noelia Martínez, Alvaro Montaño, Begoña Bermejo, Serafin Morales, María J. Echarri, Estela Vega, Blanca González-Farré, Débora Martínez, Patricia Galván, Jordi Canes, Paolo Nuciforo, Xavier Gonzalez, Aleix Prat |
X Demographics
The data shown below were collected from the profiles of 142 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 25 | 18% |
| United States | 18 | 13% |
| United Kingdom | 7 | 5% |
| Mexico | 5 | 4% |
| Italy | 4 | 3% |
| India | 3 | 2% |
| Turkey | 2 | 1% |
| United Arab Emirates | 2 | 1% |
| Brazil | 2 | 1% |
| Other | 21 | 15% |
| Unknown | 53 | 37% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 87 | 61% |
| Practitioners (doctors, other healthcare professionals) | 33 | 23% |
| Scientists | 20 | 14% |
| Science communicators (journalists, bloggers, editors) | 2 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 79 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 13 | 16% |
| Student > Ph. D. Student | 10 | 13% |
| Other | 5 | 6% |
| Student > Bachelor | 5 | 6% |
| Lecturer | 2 | 3% |
| Other | 8 | 10% |
| Unknown | 36 | 46% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 15 | 19% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 5% |
| Biochemistry, Genetics and Molecular Biology | 4 | 5% |
| Agricultural and Biological Sciences | 4 | 5% |
| Nursing and Health Professions | 3 | 4% |
| Other | 5 | 6% |
| Unknown | 44 | 56% |
Attention Score in Context
This research output has an Altmetric Attention Score of 96. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 March 2022.
All research outputs
#445,382
of 25,595,500 outputs
Outputs from Clinical Cancer Research
#232
of 13,272 outputs
Outputs of similar age
#12,034
of 434,094 outputs
Outputs of similar age from Clinical Cancer Research
#7
of 191 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,272 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,094 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 191 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.